Background. A large and consistent body of evidence supports thejudgment that elevation of total plasma blood cholesterol is a cause of myocardial infarction (MI) 
the sum of a number of lipoprotein components including low density lipoprotein cholesterol (LDL) , which is positively associated with MI, and high density lipoprotein cholesterol (HDL), which has an inverse relation.5-9 In some but not all studies, very low density lipoprotein cholesterol (VLDL) and triglycerides have been positively associated with MI. 10 Recent advances in biochemistry have facilitated the identification and quantification of lipoprotein subfractions as well as the apolipoprotein components of lipoproteins.1" HDL is composed of two principal subfractions, HDL2 and HDL3. There is clear evidence that a low level of total HDL cholesterol is directly related to MI, although whether this is due to one or both of its subfractions is as yet unclear.12-'5 Apolipoproteins play an important role in lipid metabolism.1116-18 Apolipoprotein (Apo) A-I and A-II are the major proteins of HDL, whereas Apo B is the major protein of LDL. Apo E is a constituent of VLDL and HDL; genetic variation in this protein plays a role in determining LDL cholesterol levels. The exact relation of plasma levels of each of these apolipoproteins with MI and whether these provide any additional predictive infonnation over and above lipoprotein cholesterol levels is unknown.
In this case-control study, we evaluated the interrelations of serum lipids, HDL All willing and eligible cases and controls were interviewed by one of two trained nurse-interviewers in their homes approximately 8 weeks after hospital discharge of the cases. Information was obtained on a wide variety of coronary risk factors related specifically to the time period before the infarction for the cases and before the interview for the controls. This information included the subject's medical history (diabetes, high blood pressure, body mass index, and family history of MI <60 years) and behavioral factors (level of physical activity, cigarette consumption, dietary intake, type A personality, and alcohol consumption). High blood pressure was defined as being on blood pressure medication before hospitalization for cases and before the interview for the controls. A physical activity index, expressed in kilocalories (1 kcal-4.2 ki) per week, was obtained by summing stairs climbed, blocks walked, and recreation and leisure-time activities.19 Body mass index was calculated as (weight in kilograms)/(height in meters).2 Information was collected on dietary intake during the year before infarction (for the cases) or interview (for the controls) by using a self-administered food frequency questionnaire, and total calories (1 calorie-4.2 J) as well as percentage of calories as saturated fat were calculated.20 Type A behavior was assessed using questions adapted from the Framingham Heart Study. 21 Using these methods, a total of 340 case-control pairs were interviewed, representing participation rates of approximately 84% among eligible cases and 60% among controls. Fasting venous blood samples were obtained from cases approximately 8 weeks after hospital discharge and from controls on the same day or within a week of the day of the matching case. Blood was drawn into 0.1% EDTA, and plasma obtained by centrifugation at 3,000 rpm for 30 minutes at 4°C was used fresh and unfrozen to determine total, HDL Results As shown in Table 1 , over three fourths of the study population were men (78.1%) and over the age of 50 years (79.6%). Cases were more likely to have had a history of high blood pressure or diabetes, to have family history of premature MI, to have type A personality, and to be obese, less physically active (p=0.002), and a current cigarette smoker (p=0.001). Cases on average consumed less alcohol than did controls. They also consumed more calories (p=0.028), and a somewhat larger percent of their daily calorie intake was from saturated fat (p <0.001).
Age-and sex-adjusted mean HDL cholesterol levels were 35 .0 mg/dl for cases and 43.3 mg/dl for controls (Table 2) . For HDL2 cholesterol, these values were 12.1 and 17.7 mg/dl for cases and controls, respectively, and for HDL3 cholesterol, the levels were 22.9 and 25.6 mg/dl. Cases had significantly lower levels of total HDL (p<0.0001), HDL2 (p<O.OOOl), and HDL3 cholesterol (p<O.OOOl).
These differences in total HDL cholesterol and in the subfractions HDL2 and HDL3 persisted after controlling for a large number of medical history and behavioral coronary risk factors (including history of hypertension, diabetes, family history of premature MI, body mass index, physical activity, type A personality, cigarette smoking, and alcohol consumption) and for levels of other lipids.
When the levels of total HDL, HDL2, and HDL3 cholesterol were subdivided into quartiles based on the distribution of the control population (Table 3) , each showed a significant dose-response association with MI. Specifically, those in the highest quartiles of HDL, HDL2, and HDL3 cholesterol had the lowest odds ratios (probability value for trend <0.0001 for each of the three comparisons). The (Table 3 ; probability trend=0.02).
Mean levels of Apo A-I, A-II, B, and E for cases and controls as well as odds ratios of MI by quartiles of apolipoprotein values are presented in Tables 4  and 5 . Age-and sex-adjusted mean Apo A-I levels were lower in cases than in controls (89.1 versus 101.8 mg/dl; Table 4 ). For Apo A-II, the values were 26.9 and 30.5 mg/dl for cases and controls, respectively. Both of these differences were statistically significant (p<0.0002) after control for all available coronary risk factors. After further control for levels of HDL, LDL, VLDL, and triglycerides, Apo A-I was only of borderline significance (p=0.062), but Apo A-II was statistically significant (p=0.025). When these variables were divided into quartiles (Table 5) , there were significant dose-response relations for both Apo A-I (probability trend=0.026) and Apo A-II (probability trend=0.002). The odds ratios for those in the highest quartile relative to those in the lowest were 0.46 for Apo A-I and 0.29 for Apo A-II.
For Apo B, levels were higher in cases (98.0 mg/dl) than in controls (94.1 mg/dl), but this difference was not statistically significant (p=0.134). Levels of Apo E were also higher among cases than controls (4.17 versus 3.80 mg/dl; p =0.024), but this increase was no longer statistically significant after adjustment for the other coronary risk factors and lipids. Although for both Apo B and E, the strongest associations with MI were seen among those in the highest quartile (Table  5) , in neither instance was this trend statistically significant (probability trend=0.197 and 0.084 for Apo B and E, respectively).
We also evaluated whether there was an increased level of prediction of risk of myocardial infarction through knowledge of the apolipoproteins over the information provided by the coronary risk factors and lipid values alone. As seen in Table 6 , for the four apolipoproteins taken together, there was a residual association with risk of myocardial infarction (p=0.002). This overall result, however, was demonstrable only for Apo A-I and A-LI (p=0.027 and 0.011, respectively). Neither Apo B nor E had a statistically significant residual relation with risk of MI (p=0.406 and 0.171, respectively).
Discussion
In this case-control study, total HDL cholesterol levels were significantly lower in cases than in controls even after adjustment for a large number of demographic, medical history, and behavioral coronary risk factors and for other lipid values. There was a strong inverse relation between HDL cholesterol levels and MI. Specifically, when those in the highest quartile of HDL cholesterol were compared with those in the lowest, the odds ratio was 0.15 (95% CI, 0.08-0.31). The mean levels of each major HDL cholesterol subfraction, HDL2 (p<0.0001) and HDL3 (p<0.0001), were also significantly lower in cases than in controls even after adjustment for all available coronary risk factors. Those in the highest quartile of HDL2 cholesterol had an odds ratio of 0.17 compared with those in the lowest quartile (95% CI, 0.08-0.37), and those in the highest quartile of HDL3 cholesterol had an odds ratio of 0.32 compared with the lowest quartile (95% CI, 0.17-0.59). Cases had higher levels of triglycerides than did controls even after accounting for the effects of other coronary risk factors and other lipids (p=0.044). Those in the highest quartile of triglycerides had an With respect to the apolipoproteins, the observed differences between cases and controls were consistent with the known relations of apolipoproteins with other lipoprotein-related variables. Specifically, mean levels of Apo A-I and A-LI, which are structural constituents of HDL, were lower among cases than among controls. However, Apo A-I and A-II were significantly associated with MI independently of their association with total HDL, HDL2, or HDL3
cholesterol. Plasma levels of Apo B, which is a constituent of LDL and VLDL, were somewhat higher in cases than in controls, but the differences were not statistically significant. Apo E, a constituent of VLDL and HDL, was higher among cases, but the difference did not remain statistically significant after adjustment for other coronary risk factors and lipid levels. Neither Apo B nor Apo E appeared to contribute independent information to predicting the risk of MI after adjustment for coronary risk factors and lipids. However, the apolipoprotein analyses were based on a small sample; thus, small-to-moderate effects of Apo B and E cannot be ruled out in these data.
Although cross-sectional, This study of risk factors of MI also addressed whether determining apolipoprotein levels adds information to the determination of risk that is above and beyond that obtained from lipids and coronary risk factors.282937-43 Levels of A-I and A-Il, the major apolipoproteins of HDL, have been inversely related to MI in most but not all studies.42 Apo B, the major apolipoprotein in LDL, has been positively and sometimes independently related to coronary disease.44 A possible role for Apo E, which is associated with VLDL and HDL, is suggested from the fact that it seems to play an important role in the binding of lipoproteins to surface receptors.29 In the current investigation, Apo A-I and A-II were inversely related to MI and significantly contributed additional information to prediction of risk independent of the other coronary risk factors and lipids. Neither Apo B nor Apo E added a significant amount of additional information. These findings support the belief that the apolipoproteins, especially Apo A-I and A-Il, appear promising in predicting risks of MI and may offer additional information to that available from coronary risk factors, blood lipids, and lipoprotein levels.
Several issues should be considered in the interpretation of these results. First, although the choice of neighborhood rather than hospital controls had the advantage of providing a comparison group more likely to have come from the same source population that gave rise to the cases, there was, as expected, a higher response rate among cases than controls. Although nonresponse could in theory bias the results, this seems unlikely to have occurred to any appreciable degree. The response rate among the controls varied between the neighborhoods of each of the six hospitals, and the observed associations were not appreciably different for those with higher compared with lower response rates among the controls. Further, the results obtained in this study for well-documented risk factors such as smoking, level of physical activity, and family history of premature MI were consistent with those observed in previous analytic studies.
With respect to potential confounding, one of the strengths of this study is that it was able to collect information on a wide variety of coronary risk factors including demographic, medical history, and behavioral variables. It is certainly possible that residual confounding by unmeasured factors could have affected the results, but it is unlikely to have occurred because accounting for the effects of all the available coronary risk factors did not materially affect the results.
The timing of the blood drawing could affect the lipid levels because MI is known to acutely affect lipid metabolism.45-50 For these reasons, we used blood specimens collected about 8 weeks after hospital discharge rather than those drawn in hospital. However, treatment for elevated cholesterol as well as the use after hospital discharge of 13-blockers or thiazide diuretics could also affect lipid levels. We could not control for these variables directly because the information collected in the study referred to drug use in the year before admission to the hospital for the cases and before the interview for the controls. Thus, we had no data specifically concerning the postdischarge period for the cases, and confounding by use of these agents cannot be ruled out. Nonetheless, we did adjust for past treatment for elevated cholesterol as well as reported therapy with 13- 
Summary
This study demonstrated a strong and significant inverse association between HDL cholesterol and MI even after accounting for a large number of other coronary risk factors. This study also demonstrated that both subfractions HDL2 cholesterol and HDL3 cholesterol were significantly and independently associated with MI. Consistent with their known associations with HDL, Apo A-I and A-II were inversely related to MI and significantly added information to prediction of risk over and above that provided by the coronary risk factors and lipid levels. Thus, these data indicate an important role for both HDL2 and HDL3 and also raise the possibility that Apo A-I and A-II levels may add to the risk assessment provided by lipoprotein cholesterol measurement.
